Matching the donor and recipient in HLA alleles lowers the risk of HSCT to the level of sibling transplantation. Nonetheless, some patients develop GVHD and suffer from prolonged immune system ...

Design of a phase 0 microdosing trial for correlation of platinum-induced DNA damage to chemotherapy outcomes No significant financial relationships to disclose. This is an ASCO Meeting Abstract from ...

CCAAT/enhancer-binding protein-α (C/EBPα) is a transcription factor strongly implicated in hematopoiesis through control of proliferation and differentiation of myeloid progenitors. Disruption of ...

Tamoxifen versus tamoxifen plus octreotide LAR as adjuvant therapy for early-stage breast cancer in postmenopausal women: Update of NCIC CTG MA14 trial. Background: Cytoplasmic expression of CD24, a ...